Dr. Atif Nazier Qasim, MD

Dr. Qasim practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Qasim's NPI, 1609801109, was assigned on July 12, 2006. Dr. Qasim graduated from The Johns Hopkins University School of Medicine in 2003. Dr. Qasim's California license number on file is A120620.

Dr. Qasim's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Qasim's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Qasim is also affiliated with MarinHealth Medical Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Qasim to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Qasim practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Qasim's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Qasim is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Qasim's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiac arrhythmia, cardiomyopathy, chronic hypertension, circulation problems, congestive heart failure and coronary artery disease among the conditions Dr. Qasim treats.

CMS data shows 1,767 Medicare services from Dr. Qasim across 17 procedure codes in 2024, for 957 Medicare patients. Medicare paid $97,821 for them.

CMS counts 957 Medicare patients who saw Dr. Qasim in 2024. The largest group is 65 to 74, with 393 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Qasim's median patient age at 72, with 49% women.

In 2024, Dr. Qasim wrote 1,240 Medicare Part D claims for 197 patients. 77% of them were for generic drugs. CMS names the drug for 1,081 of them, across 24 drugs with 11 or more claims each, at $296,626 in total drug cost. In 2023, CMS named 997 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Qasim for performance year 2024, reported individually. Dr. Qasim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Qasim as offering telehealth.

Dmand AI links 81 papers to Dr. Qasim, published from 2008 to 2024. 2017 was the busiest year, with 7. The most frequent topics are Coronary Artery Disease, Diabetes Mellitus, Type 2 and Calcinosis. Dr. Qasim has published most often in J Am Coll Cardiol. Dr. Qasim's most frequent co-authors are Muredach P. Reilly, MD, Daniel J. Rader, MD and Claire K. Mulvey, MD.

CMS Open Payments shows 14 general payments to Dr. Qasim from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 74% of the total. Siemens Medical Solutions USA, Inc. paid the most, $2,425.

Dmand AI lists 1 award for Dr. Qasim, most recently CMS Stage 1 EHR in 2013.

Dr. Qasim graduated from The Johns Hopkins University School of Medicine in 2003. Dr. Qasim is a member of ACC.

Dr. Qasim is in network with 8 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.